These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3643926)

  • 41. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Individual reaction steps in the release of kallidin from kininogen by tissue kallikrein.
    Fiedler F; Hinz H; Lottspeich F
    Adv Exp Med Biol; 1986; 198 Pt A():283-9. PubMed ID: 3643712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whale high-molecular-weight and low-molecular-weight kininogens.
    Semba U; Shibuya Y; Okabe H; Hayashi I; Yamamoto T
    Thromb Res; 2000 Mar; 97(6):481-90. PubMed ID: 10704658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and functional properties of the heavy and light chains of human plasma kallikrein.
    van der Graaf F; Tans G; Bouma BN; Griffin JH
    J Biol Chem; 1982 Dec; 257(23):14300-5. PubMed ID: 6815193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein.
    Mori K; Nagasawa S
    J Biochem; 1981 May; 89(5):1465-73. PubMed ID: 6168636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
    J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M; Nicoll JE; Kaplan AP
    Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
    Mori K; Sakamoto W; Nagasawa S
    J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.
    Schousboe I; Halkier T
    Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limited proteolysis of human low-molecular-mass kininogen by tissue kallikrein. Isolation and characterization of the heavy and the light chains.
    Müller-Esterl W; Rauth G; Lottspeich F; Kellermann J; Henschen A
    Eur J Biochem; 1985 May; 149(1):15-22. PubMed ID: 2581778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rat plasma high-molecular-weight kininogen. A simple method for purification and its characterization.
    Hayashi I; Kato H; Iwanaga S; Oh-ishi S
    J Biol Chem; 1985 May; 260(10):6115-23. PubMed ID: 3846594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parallel procoagulant and anticoagulant pathways for high molecular weight kininogen coagulant function.
    Olson ST; Sheffer R; Shore JD
    Agents Actions Suppl; 1992; 38 ( Pt 1)():241-8. PubMed ID: 1466276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
    Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
    J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
    Page JD; Colman RW
    J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma.
    Scicli AG; Waldmann R; Guimaraes JA; Scicli G; Carretero OA; Kato H; Han YN; Iwanaga S
    J Exp Med; 1979 Apr; 149(4):847-55. PubMed ID: 429963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen.
    Scarsdale JN; Harris RB
    J Protein Chem; 1990 Oct; 9(5):647-59. PubMed ID: 2085389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.